Literature DB >> 17009007

Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up.

Felix Distelmaier1, Raimund Fahsold, Guido Reifenberger, Martina Messing-Juenger, Jörg Schaper, Dominik T Schneider, Ulrich Göbel, Ertan Mayatepek, Thorsten Rosenbaum.   

Abstract

INTRODUCTION: Neurofibromatosis type I (NF1) is one of the most prevalent genetic diseases of the nervous system. Although the majority of NF1 patients are only mildly affected, the risk of developing malignancies is significantly increased in this population. CASE REPORT: Here, we present a 9-year-old girl with clinical stigmata of NF1 and a rapidly evolving glioblastoma multiforme. Molecular genetic analysis uncovered a novel missense mutation in Exon 32 of the NF1 gene [c.6032C>A(p.Ala2011Glu)]. DISCUSSION: The girl's death 3 days after diagnosis of the brain tumor exemplifies that NF1 still is a life-threatening disease despite its generally benign course in most patients. However, it remains questionable if a fatal course as reported here can be prevented by routine MRI screening.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009007     DOI: 10.1007/s00381-006-0222-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

Review 1.  Malignancy in neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Oncologist       Date:  2000

2.  Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo.

Authors:  Biplab Dasgupta; David H Gutmann
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.167

Review 3.  Intracranial gliomas in neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; D H Gutmann
Journal:  Am J Med Genet       Date:  1999-03-26

4.  Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.

Authors:  Reinhard E Friedrich; Lan Kluwe; C Fünsterer; V F Mautner
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

5.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

Review 6.  Pediatric high-grade gliomas.

Authors:  Alyssa T Reddy; John C Wellons
Journal:  Cancer J       Date:  2003 Mar-Apr       Impact factor: 3.360

7.  Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.

Authors:  Michaela Livia Bajenaru; Yuan Zhu; Nicolé M Hedrick; Jessica Donahoe; Luis F Parada; David H Gutmann
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

9.  Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.

Authors:  P Balestri; L Calistri; R Vivarelli; G Bartalini; L Mancini; A Berardi; A Fois
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

10.  Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1.

Authors:  M A Blazo; R A Lewis; M M Chintagumpala; M Frazier; C McCluggage; S E Plon
Journal:  Am J Med Genet A       Date:  2004-06-15       Impact factor: 2.802

View more
  4 in total

1.  Lobar haemorrhagic mass in a young girl with neurofibromatosis type 1.

Authors:  Rita Ceponiene; Michael L Levy; John Ross Crawford
Journal:  BMJ Case Rep       Date:  2013-08-23

2.  Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.

Authors:  Emre Cecen; Dilek Ince; Kamer Mutafoglu Uysal; Erdener Ozer; Riza Cetingoz; Ali Aykan Ozguven; Handan Cakmakci; Faik Sarialioglu; Nur Olgun
Journal:  Childs Nerv Syst       Date:  2011-03-26       Impact factor: 1.475

3.  Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.

Authors:  Hideyuki Arita; Yoshitaka Narita; Makoto Ohno; Yasuji Miyakita; Yoshiko Okita; Takafumi Ide; Soichiro Shibui
Journal:  Childs Nerv Syst       Date:  2012-10-30       Impact factor: 1.475

Review 4.  Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.

Authors:  Orli Michaeli; Uri Tabori
Journal:  J Korean Neurosurg Soc       Date:  2018-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.